Generic Atorvastatin Hits the Market

November 30th, 2011

Generic Atorvastatin Hits the Market

Larry Husten, PHD

The first generic version of Lipitor (atorvastatin) became available today as the exclusive patent held by Pfizer finally expired. Lipitor was by far the most successful prescription drug in history.

Watson Pharmaceuticals announced an authorized generic version. One other company, Ranbaxy, has been authorized to market atorvastatin, but has struggled to gain FDA approval of its manufacturing plant. The company has said it will launch its generic version of atorvastatin later this week.

For the next 6 months, Pfizer, Watson, and Ranbaxy are the only companies that will be authorized to sell atorvastatin. After that, however, the floodgates will open, and the price of atorvastatin will drop to pennies per day.

Here are links to a few of the many news reports and features about this major story:

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

November 30th, 2011